Skip to content
ClinCalc Pro
Menu
Antibiotic (Lincosamide) — Surgical Prophylaxis

Clindamycin (Surgical Prophylaxis — Penicillin Allergy)

Brand names: Dalacin C

Clindamycin is a lincosamide antibiotic used here as an alternative agent for surgical antibiotic prophylaxis in patients with penicillin or cephalosporin allergy, providing cover against staphylococci, streptococci, and anaerobes.

Dosing — not shown for this use

The product information we hold does not support a dose for this page's specific use, route or population, so none is shown. Follow your local or national guideline, and confirm against the product SmPC.

The licensed dosing — for the medicine's licensed uses, which may differ from this page's — is on Clindamycin.

Clinical monograph

How it works

It inhibits bacterial protein synthesis by binding the 50S ribosomal subunit, acting in a bacteriostatic manner.

Prescribing in practice

  • It is strongly associated with Clostridioides difficile infection, so use should be reserved, kept short, and stopped promptly if significant diarrhoea develops.
  • When given intravenously it should be infused slowly rather than as a rapid bolus to avoid cardiovascular reactions.
  • It is a useful choice in beta-lactam allergy but does not provide the Gram-negative cover that some procedures require, so additional cover may be needed.

Monitoring

Monitor for diarrhoea and signs of Clostridioides difficile infection, clinical response, and infusion-related effects with intravenous use.

Counselling the patient

  • Report any diarrhoea, especially if severe, watery, or with blood, even after finishing the antibiotic.
  • This may be given because you are allergic to penicillin-type antibiotics.
  • Tell staff about all your allergies and any previous bowel infections.

Evidence & guidelines

Clindamycin is an established option for surgical prophylaxis in beta-lactam allergy, with its Clostridioides difficile risk well documented in stewardship guidance.

Reference: WHO SSI Guidelines 2016; PHE Penicillin Allergy Guidance; SIGN 104; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.